Results 171 to 180 of about 8,201 (208)
Some of the next articles are maybe not open access.

The Spectrum of Small Intestinal Bacterial Overgrowth (SIBO)

Current Gastroenterology Reports, 2019
To critically review recent (past 3 years) literature on the definition, diagnosis, and management of small intestinal bacterial overgrowth (SIBO).While various series continue to illustrate the occurrence of SIBO in disease states where well-known risk factors for its occurrence are present (hypochlorhydria, disorders of intestinal structure or motor ...
openaire   +2 more sources

Is SIBO A Real Condition?

Alternative therapies in health and medicine, 2019
Small intestinal bacterial overgrowth (SIBO) has gained popularity on the internet in addition to certain clinical and research circles. This interest has expanded awareness of important new dietary, nutraceutical, and pharmaceutical treatments in addition to laboratory evaluation assessment options.
openaire   +1 more source

[SIBO, from myth to reality].

La Revue de medecine interne
Digestive functional disorders are among the most frequent reasons for medical consultation and a significant source of medical wandering. Therapeutic management of these patients is difficult, particularly due to the absence of specific treatment linked to an incomplete understanding of the pathophysiological mechanisms.
Thomas, Escoda   +3 more
openaire   +1 more source

The IBS and SIBO dilemma: Here we go again

Digestive and Liver Disease
NA
Marasco, Giovanni   +2 more
openaire   +4 more sources

Testing for SIBO

Alternative and Complementary Therapies, 2016
openaire   +1 more source

Influence of Body Composition and Specific Anthropometric Parameters on SIBO Type

Nutrients, 2023
Małgorzata Drywień   +1 more
exaly  

Oral psoriasis and SIBO: is there a link?

Journal of the European Academy of Dermatology and Venereology, 2018
Drago, F.   +5 more
openaire   +2 more sources

SIBO – pharmacotherapy, supportive therapies, and the impact of comorbidities

The article presents current therapeutic strategies used in the treatment of small intestinal bacterial overgrowth (SIBO) and discusses the role of comorbidities affecting treatment efficacy and the risk of SIBO recurrence. Standard SIBO therapy involves the use of rifaximin and, in cases of methane-producing SIBO (IMO), metronidazole and neomycin ...
Świder, Marta, Szkutnik-Fiedler, Danuta
openaire   +1 more source

Home - About - Disclaimer - Privacy